Search research articles
Contact Us
Filters
Showing results (351-360 of 531) with videos related to
Page
of 54
Sort By:
Pharmacotherapy
|
December 28, 1999
Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital
C M Weingarten, M J Rybak, B E Jahns, et al.
International Journal of Antimicrobial Agents
|
August 16, 2011
Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus
Diixa Patel, Mashkur Husain, Celine Vidaillac, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 1999
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity
M J Rybak, B J Abate, S L Kang, et al.
Infectious Diseases and Therapy
|
November 23, 2017
Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis
Kimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
The Journal of Antimicrobial Chemotherapy
|
June 28, 2020
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights
Razieh Kebriaei, Seth A Rice, Nivedita B Singh, et al.
Pharmacotherapy
|
November 29, 2007
Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes
Susan L Davis, Peggy S McKinnon, Levi M Hall, et al.
The Journal of Infectious Diseases
|
March 30, 2013
Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus
Celine Vidaillac, Susana Gardete, Ryan Tewhey, et al.
Drug Discovery Today
|
October 22, 2020
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance
Kushal Vanamala, Katyayani Tatiparti, Ketki Bhise, et al.
Open Forum Infectious Diseases
|
June 25, 2020
Corrigendum to: The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infections Treated With Vancomycin
Evan J Zasowski, Trang D Trinh, Safana M Atwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2013
Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study
Kyle P Murray, Jing J Zhao, Susan L Davis, et al.
Page
of 54
Search research articles
Search
Showing results (351-360 of 531) with videos related to
Sort By:
Page
of 54
Pharmacotherapy
|
December 28, 1999
Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital
C M Weingarten, M J Rybak, B E Jahns, et al.
International Journal of Antimicrobial Agents
|
August 16, 2011
Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus
Diixa Patel, Mashkur Husain, Celine Vidaillac, et al.
Antimicrobial Agents and Chemotherapy
|
July 2, 1999
Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity
M J Rybak, B J Abate, S L Kang, et al.
Infectious Diseases and Therapy
|
November 23, 2017
Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis
Kimberly C Claeys, Evan J Zasowski, Trang D Trinh, et al.
The Journal of Antimicrobial Chemotherapy
|
June 28, 2020
Combinations of (lipo)glycopeptides with β-lactams against MRSA: susceptibility insights
Razieh Kebriaei, Seth A Rice, Nivedita B Singh, et al.
Pharmacotherapy
|
November 29, 2007
Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes
Susan L Davis, Peggy S McKinnon, Levi M Hall, et al.
The Journal of Infectious Diseases
|
March 30, 2013
Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus
Celine Vidaillac, Susana Gardete, Ryan Tewhey, et al.
Drug Discovery Today
|
October 22, 2020
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance
Kushal Vanamala, Katyayani Tatiparti, Ketki Bhise, et al.
Open Forum Infectious Diseases
|
June 25, 2020
Corrigendum to: The Impact of Concomitant Empiric Cefepime on Patient Outcomes of Methicillin-Resistant <i>Staphylococcus aureus</i> Bloodstream Infections Treated With Vancomycin
Evan J Zasowski, Trang D Trinh, Safana M Atwan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 2, 2013
Early use of daptomycin versus vancomycin for methicillin-resistant Staphylococcus aureus bacteremia with vancomycin minimum inhibitory concentration >1 mg/L: a matched cohort study
Kyle P Murray, Jing J Zhao, Susan L Davis, et al.
Page
of 54